Is There a Cognitive Decline in Pediatric Patients Following Epilepsy Surgery?

Konstantin L Makridis1, Sebastian Hoyer2, Christian E Elger3

  • 1Department of Pediatric Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Center for Chronically Sick Children, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Epilepsy Center for Children and Adolescents, Charité - Universitätsmedizin Berlin, Berlin, Germany; Institute of Cell- and Neurobiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Insights

Epilepsy surgery can cure drug-resistant epilepsy (DRE) and improve cognitive development in children. While IQ scores may slightly decrease, individual raw scores show cognitive progress, indicating successful surgical outcomes.

Area of Science:

  • Pediatric Neurology
  • Developmental Neuroscience
  • Epileptology

Background:

  • Drug-resistant epilepsy (DRE) in children and adolescents often requires surgical intervention for potential cure.
  • Epilepsy surgery may offer benefits beyond seizure control, including positive effects on cognitive development.
  • The impact of epilepsy surgery on the cognitive trajectory of young patients remains an area of critical investigation.

Purpose of the Study:

  • To analyze the cognitive development of children and adolescents with DRE before and after undergoing epilepsy surgery.
  • To determine if epilepsy surgery leads to cognitive deterioration or improvement in pediatric patients.
  • To evaluate the correlation between IQ changes and actual cognitive abilities post-surgery.

Main Methods:

  • Retrospective evaluation of cognitive development in pediatric patients with DRE.
  • Inclusion of 53 children and adolescents who underwent epilepsy surgery.
  • Assessment of cognitive function using standardized tests and caretaker reports, comparing pre- and post-operative data.

Main Results:

  • A high seizure freedom rate (86.8%) was achieved post-surgery.
  • Presurgically, 76.7% of patients exhibited cognitive impairment, with a median IQ/development quotient of 74.
  • Post-surgery, caretakers reported developmental progress in all patients, despite a slight median IQ decrease; individual raw scores indicated cognitive gains.

Conclusions:

  • Epilepsy surgery does not result in cognitive deterioration in pediatric patients.
  • A decrease in IQ points does not necessarily reflect a loss of cognitive abilities; individual raw score analysis is crucial.
  • Pediatric patients undergoing epilepsy surgery show individual cognitive benefits, even if their development speed is slower than peers.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
234
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
468
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
226